Cargando…

Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia

BACKGROUND: Refining risk stratification of cytogenetically normal AML (CN-AML) cases is important for decision making and tailoring of therapy. In this context genetic and epigenetic mutations was considered. Among these epigenetic regulators are DNMT3A & TET2 genes. Therefore, the aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aref, Salah, Sallam, Nahed, Abd Elaziz, Sherin, Salama, Osama, Al Ashwah, Shaimaa, Ayed, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971478/ https://www.ncbi.nlm.nih.gov/pubmed/36580013 http://dx.doi.org/10.31557/APJCP.2022.23.12.4299

Ejemplares similares

Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients
por: Aref, Salah, et al.
Publicado: (2020)

Wilms Tumor 1 Gene Mutations in Patients with Cytogenetically Normal Acute Myeloid Leukemia
por: Aref, Salah, et al.
Publicado: (2014)

Prognostic value of CD25/CD123 pattern of expression in acute myeloid leukemia patients with normal cytogenetic
por: Aref, Salah, et al.
Publicado: (2020)

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
por: Wang, Jinghan, et al.
Publicado: (2018)

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
por: Niederwieser, Christian, et al.
Publicado: (2014)

The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review
por: Mansour, Reham Osama, et al.
Publicado: (2023)

The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia
por: Chen, Xian, et al.
Publicado: (2023)

Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia
por: Wang, Mengning, et al.
Publicado: (2017)

Implications of Glutathione Peroxidase 3 Expression in a Cohort of Egyptian Patients with Acute Myeloid Leukemia
por: Shaaban, Yasmine, et al.
Publicado: (2020)

DNA sequencing of a cytogenetically normal acute myeloid leukemia genome
por: Ley, Timothy J, et al.
Publicado: (2008)

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics
por: Gregory, Tara K, et al.
Publicado: (2009)

Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia
por: Lai, Rui, et al.
Publicado: (2020)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
por: Sahoo, Ranjit Kumar, et al.
Publicado: (2013)

The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia
por: Cao, Ling, et al.
Publicado: (2019)

Association of SDF-1 Gene Polymorphism with Increased Risk of Acute Myeloid Leukemia Patients
por: Aladle, Doaa Abd Allah M, et al.
Publicado: (2021)

High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia
por: Song, Ying, et al.
Publicado: (2019)

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
por: Tsui, Sze P., et al.
Publicado: (2020)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Clinical Impact of Percentage of Natural Killer Cells and Natural Killer-Like T Cell Population in Acute Myeloid Leukemia
por: Jamal, Esraa, et al.
Publicado: (2020)

Altered expression of imprinted genes in patients with cytogenetically normal‑acute myeloid leukemia: Implications for leukemogenesis and survival outcomes
por: Yang, Ming-Yu, et al.
Publicado: (2023)

ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma
por: Belani, R, et al.
Publicado: (2014)

Combined heterozygosity of FLT3(ITD), TET2, and DNMT3A results in aggressive leukemia
por: Ramdas, Baskar, et al.
Publicado: (2022)

Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics
por: Fernandez-Mercado, Marta, et al.
Publicado: (2012)

Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients
por: Bou Samra, Elias, et al.
Publicado: (2012)

High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2016)

Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model
por: Yang, Liu, et al.
Publicado: (2021)

Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
por: Lee, Young Eun, et al.
Publicado: (2022)

DNMT3a and TET2 in adipocyte insulin sensitivity
por: Villivalam, Sneha Damal, et al.
Publicado: (2018)

An uncommon case of chronic myeloid leukemia with variant cytogenetics
por: Abdulla, Mohammad A., et al.
Publicado: (2018)

Expression and prognosis analysis of TET family in acute myeloid leukemia
por: Zhang, Tingjuan, et al.
Publicado: (2020)

Expression and prognosis analysis of DNMT family in acute myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2020)

Characteristics of DNMT3A mutations in acute myeloid leukemia
por: Park, Dong Jin, et al.
Publicado: (2020)

The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia
por: Nabil, Reem, et al.
Publicado: (2022)

Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Shi, Jin-long, et al.
Publicado: (2015)

KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

Evaluation of BAALC gene expression in normal cytogenetic acute myeloid leukemia patients in north-east of Iran
por: Amirpour, Mojgan, et al.
Publicado: (2016)

Incidence and Prognostic Impact of DNMT3A Mutations in Korean Normal Karyotype Acute Myeloid Leukemia Patients
por: Park, Sang Hyuk, et al.
Publicado: (2015)

A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes
por: Hackl, Hubert, et al.
Publicado: (2015)

TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia
por: Qian, Sixuan, et al.
Publicado: (2016)

Regulation of CpG methylation by Dnmt and Tet in pluripotent stem cells
por: HORII, Takuro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_30r4ii9ujnks63epn6mlare175